So, I decided to take BIT for a spin and to reply to one of their invitations. Here is the one that I received:

On Nov 3, 2011, at 4:24 AM, Ella wrote:

2^nd Annual Symposia of Bacteriology and Infection (SBI-2012)

Time: July 30-August 1, 2012

Place: Guangzhou, China

Website: http://www.bitlifesciences.com/wcm2012/fullprogram.asp

Dear Dr. [my name],

BIT’s 2^nd Annual Symposium of Bacteriology and Infection (SBI-2012) hosted by Information Research Center of International Talent, SAFEA and China Medicinal Biotech Association will take place from 30 July to 1 August, 2012 in Guangzhou, China. As the operating organization, BIT World Congress cordially invites you to be a speaker at SBI 2-1: Old vs New Antibacterial Targets of Superbugs of the congress and deliver a lecture in your expertise.

The first conference of SBI-2011 has been held successfully in the past year as one of the sub-conferences of Annual World Congress of Microbes in Beijing China with more than 400 participants from 48 countries and regions. The second congress promises to be an even greater event that will emphasize practical and advanced ideas for accelerating bacteria research and development. It now is time for more experts and scholars as well as industrials leaders to join the 2^nd SBI-2012 in Guangzhou to take the subject into a higher study standard.

The program of SBI-2012 this will conclude 4 major aspects, please check the detailed program followed:

SBI-1：Breaking Research on Superbugs

SBI 1-1: Prevention, Surveillance and Statistics of Resistance to Antibiotics and Biocides

SBI 1-2: Revisitingbβ-Lactamase-Associated Resistance Mechanisms

SBI 1-3: Methicillin-resistant Staphylococcus aureus (MRSA)

SBI 1-4: Vancomycin Intermediate/Resistant Staphylococcus aureus (VISA/VRSA), and Vancomycin-resistant Enterococcus (VRE)

SBI 1-5: Helicobacter spp.and other Gastrointestinal Infectious Diseases

SBI 1-6: Escherichia coli O157: H7 and other STEC

SBI 1-7: Cronobacter spp (Enterobacter sakazakii)

SBI 1-8: Salmonella: from Basic Science to Clinical Issues

SBI-2：Drug Discovery and Development for MDR Strains and Superbugs

SBI 2-1: Old vs New Antibacterial Targets of Superbugs

SBI 2-2: Development of Effective Antibiotics against MRSA, VRE and VRSA

SBI 2-3: New Strategies of Discovering Antibacterial Agents from Natural Products

SBI 2-4: Clinical Trials on Novel Antibacterials

SBI-3：Tuberculosis

SBI 3-1: Immunology, Cell Biology and Innovative Vaccines of Tuberculosis

SBI 3-2: Mycobacterium Tuberculosis

SBI 3-3: Diagnosis of Tuberculosis

SBI-4：Translational Medicine for Antibacterial Drug Development

SBI 4-1: New Approaches to Antibacterial Drug Discovery

SBI 4-2: Multidrug Resistance

SBI 4-3: New Drug Development for Bad Bugs

If you would like to give an oral presentation at this conference, please submit title by email to ella@bitconferences.com. All proposals are subject to review by the scientific advisory board to ensure the overall quality of the conference. For further questions,please visit Website: http://www.bitlifesciences.com/wcm2012/fullprogram.asp

We look forward to seeing you join us at this influential event in Guangzhou next year.

Sincerely,

Ms. Ella Cheng 

Program Coordinator

Organizing Committee of SBI-2012, China

East Area, F11, Building 1, 

Dalian Ascendas IT Park, 

1 Hui Xian Yuan,

Dalian Hi-tech Industrial Zone,

LN 116025, China 

Tel: 0086-411-84799609-813

Fax: 0086-411-84799629

Email: ella@bitconferences.com